TA
Tarsus Pharmaceuticals, Inc.
TARS · NASDAQ
$78.09 -1.01% (-$0.80)
1M +7.25%
Market Cap $3.36B
P/E Ratio -
Div. Yield -
ROE 13.53%
Bulios Fair Price
$87.61
12.2% upside
Trenutna cena
$78.09
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TARS trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
7 /100
Expensive P/B 9.69x
P/FCF 54.59x
P/S 5.54x
Growth
100 /100
Growing Book val. growth 21.20%
Rev. growth 159.54%
FCF growth N/A
Profitability
40 /100
Moderate Net margin 7.67%
Op. margin 8.00%
FCF margin 10.15%
Quality
12 /100
Poor ROE 13.53%
ROA 7.60%
Asset turnover 0.99x
Debt
69 /100
Low Current ratio 3.20x
Int. coverage -4.36x
Debt/Equity 0.26x
Stability
25 /100
Unstable Rev. volatility 522.43%
EPS volatility 72.09%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TARS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Bobak R. Azamian
Employees
370
Headquarters
Irvine
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report